 |
|
Elevated levels of soluble ST2 but not galectin-3 are associated with increased risk of mortality in hemodialysis patients
Ae Jin Kim, Han Ro, Hyunsook Kim, Kwang-Pil Ko, Jae Hyun Chang, Hyun Hee Lee, Wookyung Chung, Ji Yong Jung
Kidney Res Clin Pract. 2021;40(1):109-119. Published online 2021 Mar 5 DOI: https://doi.org/10.23876/j.krcp.20.133
|
|
Citations to this article as recorded by
 Association of serum galectin-3 levels with mortality and cardiovascular disease outcomes in hemodialysis patients: a systematic review and dose–response meta-analysis
Ioannis Bellos, Smaragdi Marinaki, Pagona Lagiou, Vassiliki Benetou
International Urology and Nephrology.2024;[Epub] CrossRef Emotional and cognitive changes in chronic kidney disease
Duk-Soo Kim, Seong-Wook Kim, Hyo-Wook Gil
The Korean Journal of Internal Medicine.2022; 37(3): 489. CrossRef
|